| 1. |
Hedinger C, Williams ED, Sobin LH. The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer, 1989, 63(5): 908-911.
|
| 2. |
Hong YR, Yan CX, Mo GQ, et al. Conventional US, elastography, and contrast enhanced US features of papillary thyroid microcarcinoma predict central compartment lymph node metastases. Sci Rep, 2015, 5: 7748.
|
| 3. |
Choi JB, Lee WK, Lee SG, et al. Long-term oncologic outcomes of papillary thyroid microcarcinoma according to the presence of clinically apparent lymph node metastasis: a large retrospective analysis of 5 348 patients. Cancer Manag Res, 2018, 10: 2883-2891.
|
| 4. |
Kim JY, Jung EJ, Park T, et al. Impact of tumor size on subclinical central lymph node metastasis in papillary thyroid microcarcinoma depends on age. World J Surg Oncol, 2015, 13: 88.
|
| 5. |
Liu LS, Liang J, Li JH, et al. The incidence and risk factors for central lymph node metastasis in cN0 papillary thyroid microcarcinoma: a meta-analysis. Eur Arch Otorhinolaryngol, 2017, 274(3): 1327-1338.
|
| 6. |
Moo TA, McGill J, Allendorf J, et al. Impact of prophylactic central neck lymph node dissection on early recurrence in papillary thyroid carcinoma. World J Surg, 2010, 34(6): 1187-1191.
|
| 7. |
Chang YW, Kim HS, Kim HY, et al. Should central lymph node dissection be considered for all papillary thyroid microcarcinoma? Asian J Surg, 2016, 39(4): 197-201.
|
| 8. |
李茵, 楊中元, 李秋梨, 等. 分化型甲狀腺癌區域淋巴結清掃策略及爭議. 中國實用外科雜志, 2015, 35(6): 642-646.
|
| 9. |
He Q, Zhuang D, Zheng L, et al. The surgical management of papillary thyroid microcarcinoma: a 162-month single-center experience of 273 cases. Am Surg, 2012, 78(11): 1215-1218.
|
| 10. |
Roh JL, Kim JM, Park CI. Central cervical nodal metastasis from papillary thyroid microcarcinoma: pattern and factors predictive of nodal metastasis. Ann Surg Oncol, 2008, 15(9): 2482-2486.
|
| 11. |
Heid IM, Jackson AU, Randall JC, et al. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet, 2010, 42(11): 949-960.
|
| 12. |
李曉京, 楊樂, 馬斌林. 1988 例甲狀腺微小乳頭狀癌頸部中央區淋巴結轉移危險因素分析. 臨床耳鼻咽喉頭頸外科雜志, 2017, 31(1): 52-57.
|
| 13. |
王猛, 魏璽, 鄭向前, 等. 甲狀腺微小乳頭狀癌臨床病理特征與中央區淋巴結轉移的相關性探討. 天津醫科大學學報, 2018, 24(2): 138-141.
|
| 14. |
劉鵬杰, 唐銘, 鄧智勇, 等. BRAFV600E 基因突變與甲狀腺微小乳頭狀癌淋巴結轉移的相關性研究. 現代腫瘤醫學, 2019, 27(4): 552-556.
|
| 15. |
禹樂, 朱啟淦, 溫路生, 等. BRAFV600E 基因突變與甲狀腺微小乳頭狀癌臨床病理特征的相關性. 山西醫科大學學報, 2019, 50(9): 1214-1217.
|
| 16. |
Pitoia F, Miyauchi A. 2015 American thyroid association guidelines for thyroid nodules and differentiated thyroid cancer and their implementation in various care settings. Thyroid, 2016, 26(2): 319-321.
|
| 17. |
Takami H, Ito Y, Noguchi H, et al. Treatment of thyroid tumor: Japanese clinical guidelines. Tokyo: Springer, 2013: 111-113.
|
| 18. |
中國抗癌協會甲狀腺癌專業委員會(CATO). 甲狀腺微小乳頭狀癌診斷與治療中國專家共識(2016 版). 中國腫瘤臨床, 2016, 43(10): 405-411.
|
| 19. |
Lee HS, Roh JL, Gong G, et al. Risk factors for re-recurrence after first reoperative surgery for locoregional recurrent/persistent papillary thyroid carcinoma. World J Surg, 2015, 39(8): 1943-1950.
|
| 20. |
鄭玨如, 戴磊, 吳賢江, 等. 甲狀腺患側葉聯合峽部切除術治療甲狀腺微小乳頭狀癌的近遠期療效. 中華全科醫學, 2019, 17(4): 568-570, 656.
|
| 21. |
張偉偉, 李向農. 三種術式在甲狀腺微小乳頭狀癌外科治療中的應用效果比較. 中華普外科手術學雜志(電子版), 2017, 11(5): 397-399.
|
| 22. |
伊丹丹, 黃韜, 宋鵬, 等. 甲狀腺微小乳頭狀癌手術方式對腫瘤復發影響的 meta 分析. 東南大學學報(醫學版), 2017, 36(1): 48-52.
|
| 23. |
韓茜, 張廣, 孫輝. 超聲引導下熱消融治療甲狀腺微小乳頭狀癌研究進展. 中國普外基礎與臨床雜志, 2017, 24(9): 1156-1160.
|
| 24. |
李建如, 羅渝昆. 超聲引導下射頻消融治療甲狀腺微小乳頭狀癌的初步研究. 中國人民解放軍醫學院, 2016.
|
| 25. |
Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg, 2010, 34(1): 28-35.
|
| 26. |
Noguchi S, Yamashita H, Uchino S, et al. Papillary microcarcinoma. World J Surg, 2008, 32(5): 747-753.
|